Jim Hoffman on a Unifying Therapy: Extracorporeal NET Removal for Lupus and Autoimmune Organ Injury
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn:
“Chronic dysregulated NETosis induction and inadequate NET clearance are increasingly recognized as common mechanisms of worsening disease progression, adversely impacting the performance of multiple organs, including the brain and CNS.
Case study treatments suggest specfically targeting extracorporeal removal of NETs from the blood dramatically helps reduce the severity and frequency of severe Lupus flares and very likely offers hope in protecting against various other organ injuries and improving the health of patients suffering from a diverse array of overlapping lupus-like autoimmune organ dysfunctions, including neuropsychiatric and neurodegeneration in patients who have not been officially diagnosed as having SLE but nevertheless suffer from NETosis dysregulation and share similar symptoms.
For more research on NETosis dysregulation and its likely impact contributing to neurodegeneration and neuropsychiatric disorders, visit here.”
Read more about neuropsychiatric lupus.
Get insights from Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch